
Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman


KKR today announced the launch of Allyntra (&#34;Allyntra&#34; or the &#34;Company&#34;), a newly formed precision-engineered solutions

<p xmlns="http://www.w3.org/1999/xhtml" class="bwalignc">
<i xmlns="http://www.w3.org/1999/xhtml">Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman</i>

</p><p xmlns="http://www.w3.org/1999/xhtml">
KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

</p><p xmlns="http://www.w3.org/1999/xhtml" id="news-body-cta">This press release features multimedia. View the full release here: <a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260707491568/en/" rel="nofollow">https://www.businesswire.com/news/home/20260707491568/en/</a></p><p xmlns="http://www.w3.org/1999/xhtml">
Robbie Atkinson will be appointed as Chief Executive Officer of Allyntra and Brian Highley as Chairman. Together, they bring deep experience building and scaling global manufacturing organizations through operational excellence and strategic leadership. Most recently, Mr. Atkinson served as CEO and President of Medical Manufacturing Technologies (MMT), where he led the company’s strategy, operations, and growth through a period of significant expansion, culminating in its successful sale to Perimeter Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/PRM">PRM</a>). Mr. Highley brings more than 30 years of experience across the medical technology industry, having previously served as CEO of Cirtec, where he scaled the company meaningfully from two sites into one of the leading providers of end-to-end services to medical technology OEMs, including design, engineering, prototyping, and manufacturing solutions.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"The pace of innovation across medical technology and other highly engineered industries continues to accelerate," said Robbie Atkinson, Chief Executive Officer of Allyntra. "As these technologies become more sophisticated, customers are looking for partners who can help them move faster, solve increasingly complex challenges, and bring new ideas to life. That’s exactly the opportunity I see for Allyntra."

</p><p xmlns="http://www.w3.org/1999/xhtml">
"Throughout my career, I’ve learned that the companies that endure are the ones that combine technical excellence with a willingness to continue evolving alongside their customers," said Brian Highley, Chairman of Allyntra. "Those are the qualities I believe will define Allyntra, and I’m excited to help shape its future by working alongside Robbie and the team."

</p><p xmlns="http://www.w3.org/1999/xhtml">
"Our deepened commitment to Allyntra reflects our confidence in the market opportunity and Robbie’s and Brian’s ability to bring the Allyntra vision to life. Since first investing in Precipart in 2023, we’ve become increasingly convinced of the opportunity to create a distinctive precision-engineered solutions platform. We’re pleased to continue our strategic partnership with the Laubscher family, who will remain a meaningful shareholder," said Ali Satvat, Global Head of Health Care Strategic Growth and Co-Head of Americas Private Equity Health Care at KKR, and Anuv Ratan, Managing Director at KKR.

</p><p xmlns="http://www.w3.org/1999/xhtml">
As part of this platform launch, Oliver Laubscher will elevate to join the Allyntra Board of Directors and transition from his role as CEO of Precipart.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"For more than 70 years, Precipart has earned its customers’ trust through engineering excellence, innovation, and a relentless focus on quality," said Oliver Laubscher. "I look forward to continuing to work with KKR, Robbie, and Brian to support Allyntra’s next chapter of growth — building on our legacy and the culture that built it and furthering our mission to help customers "engineer possible"."

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About KKR</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit, and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life, and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/KKR">KKR</a>), please visit KKR’s website at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.kkr.com&amp;esheet=54566825&amp;newsitemid=20260707491568&amp;lan=en-US&amp;anchor=www.kkr.com&amp;index=1&amp;md5=dffc7955f5937e64d46ab75a736d913e" shape="rect">www.kkr.com</a>. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.globalatlantic.com&amp;esheet=54566825&amp;newsitemid=20260707491568&amp;lan=en-US&amp;anchor=www.globalatlantic.com&amp;index=2&amp;md5=4846ef5e5420663c5a5b9ff345218f36" shape="rect">www.globalatlantic.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About Allyntra</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Allyntra is a leading engineered solutions partner to the medical technology industry, specializing in the design, development, and manufacture of highly engineered components and assemblies for advanced surgical applications. We collaborate with the world’s leading medtech innovators to accelerate the development and commercialization of next-generation technologies, including robotic-assisted surgery, minimally invasive surgery, and advanced surgical systems.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260707491568r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260707491568/en/" rel="nofollow">https://www.businesswire.com/news/home/20260707491568/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">KKR
<br xmlns="http://www.w3.org/1999/xhtml"></br></b>Media
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:media@kkr.com" shape="rect">media@kkr.com 
</a><br xmlns="http://www.w3.org/1999/xhtml"></br>
<br xmlns="http://www.w3.org/1999/xhtml"></br><b xmlns="http://www.w3.org/1999/xhtml">Allyntra
<br xmlns="http://www.w3.org/1999/xhtml"></br></b>Media
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:media@allyntra.com" shape="rect">media@allyntra.com</a>

</p>

KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

KKR launches Allyntra to scale precision-engineered medtech platform

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman


KKR today announced the launch of Allyntra (&amp;#34;Allyntra&amp;#34; or the &amp;#34;Company&amp;#34;), a newly formed precision-engineered solutions</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>KKR unveiled Allyntra, a new precision-engineered solutions platform anchored by Precipart, with capital to pursue bolt-on acquisitions and growth. Robbie Atkinson will lead as CEO and Brian Highley as Chairman, with Oliver Laubscher joining the board as Precipart transitions. The move broadens KKR&#039;s healthcare technology footprint and could lift value over the coming years through expanded capabilities and customer deployments.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>KKR launches Allyntra, a precision-engineered platform anchored by Precipart.</li><li>Robbie Atkinson named CEO; Brian Highley named Chairman.</li><li>KKR commits meaningful capital to acquire and integrate growth.</li><li>Oliver Laubscher joins Allyntra board; Precipart transition underway.</li><li>Allyntra targets medical technology and other precision end markets.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>KKR &amp; Co. Inc. (KKR)</strong>: Leading investor behind Allyntra; driving platform expansion in healthcare.</li><li><strong>Allyntra</strong>: New private platform for precision-engineered medtech components and assemblies.</li><li><strong>Precipart</strong>: Foundational business for Allyntra; transitioning leadership to Allyntra board.</li><li><strong>Robbie Atkinson</strong>: Appointed CEO of Allyntra; former CEO of MMT.</li><li><strong>Brian Highley</strong>: Appointed Chairman of Allyntra; extensive medtech leadership background.</li><li><strong>Oliver Laubscher</strong>: To join Allyntra board; transitioning from Precipart CEO.</li><li><strong>Perimeter Solutions, Inc. (PRM)</strong>: MMT sale reference; contextual benchmark for medtech exits; not a direct KKR exposure.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments; fits as a platform-formation and M&amp;A-led growth move within healthcare/engineered solutions.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Allyntra launch signals accelerated platform-building in KKR&#039;s healthcare portfolio.</li><li>Leadership changes and board transition may speed integration and synergies.</li><li>KKR&#039;s backing provides capital for aggressive bolt-ons and geographic expansion.</li><li>Precipart linkage may elevate visibility of KKR&#039;s strategic healthcare thesis.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Date of press release: July 7, 2026.</li><li>Allyntra formed to integrate Precipart with other precision-engineered businesses.</li><li>KKR&#039;s Health Care Strategic Growth Fund II backs Allyntra&#039;s growth plan.</li><li>Robbie Atkinson appointed CEO; Brian Highley appointed Chairman.</li><li>Oliver Laubscher to join Allyntra Board; transition from Precipart.</li><li>Precipart has been invested by KKR since 2023.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Allyntra expands KKR&#039;s healthcare platform; expect bolt-on deals and margin growth over 12–24 months.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml" class="bwalignc">
<i xmlns="http://www.w3.org/1999/xhtml">Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman</i>

</p><p xmlns="http://www.w3.org/1999/xhtml">
KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

</p><p xmlns="http://www.w3.org/1999/xhtml" id="news-body-cta">This press release features multimedia. View the full release here: <a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260707491568/en/" rel="nofollow">https://www.businesswire.com/news/home/20260707491568/en/</a></p><p xmlns="http://www.w3.org/1999/xhtml">
Robbie Atkinson will be appointed as Chief Executive Officer of Allyntra and Brian Highley as Chairman. Together, they bring deep experience building and scaling global manufacturing organizations through operational excellence and strategic leadership. Most recently, Mr. Atkinson served as CEO and President of Medical Manufacturing Technologies (MMT), where he led the company’s strategy, operations, and growth through a period of significant expansion, culminating in its successful sale to Perimeter Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/PRM">PRM</a>). Mr. Highley brings more than 30 years of experience across the medical technology industry, having previously served as CEO of Cirtec, where he scaled the company meaningfully from two sites into one of the leading providers of end-to-end services to medical technology OEMs, including design, engineering, prototyping, and manufacturing solutions.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"The pace of innovation across medical technology and other highly engineered industries continues to accelerate," said Robbie Atkinson, Chief Executive Officer of Allyntra. "As these technologies become more sophisticated, customers are looking for partners who can help them move faster, solve increasingly complex challenges, and bring new ideas to life. That’s exactly the opportunity I see for Allyntra."

</p><p xmlns="http://www.w3.org/1999/xhtml">
"Throughout my career, I’ve learned that the companies that endure are the ones that combine technical excellence with a willingness to continue evolving alongside their customers," said Brian Highley, Chairman of Allyntra. "Those are the qualities I believe will define Allyntra, and I’m excited to help shape its future by working alongside Robbie and the team."

</p><p xmlns="http://www.w3.org/1999/xhtml">
"Our deepened commitment to Allyntra reflects our confidence in the market opportunity and Robbie’s and Brian’s ability to bring the Allyntra vision to life. Since first investing in Precipart in 2023, we’ve become increasingly convinced of the opportunity to create a distinctive precision-engineered solutions platform. We’re pleased to continue our strategic partnership with the Laubscher family, who will remain a meaningful shareholder," said Ali Satvat, Global Head of Health Care Strategic Growth and Co-Head of Americas Private Equity Health Care at KKR, and Anuv Ratan, Managing Director at KKR.

</p><p xmlns="http://www.w3.org/1999/xhtml">
As part of this platform launch, Oliver Laubscher will elevate to join the Allyntra Board of Directors and transition from his role as CEO of Precipart.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"For more than 70 years, Precipart has earned its customers’ trust through engineering excellence, innovation, and a relentless focus on quality," said Oliver Laubscher. "I look forward to continuing to work with KKR, Robbie, and Brian to support Allyntra’s next chapter of growth — building on our legacy and the culture that built it and furthering our mission to help customers "engineer possible"."

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About KKR</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit, and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life, and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/KKR">KKR</a>), please visit KKR’s website at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.kkr.com&amp;esheet=54566825&amp;newsitemid=20260707491568&amp;lan=en-US&amp;anchor=www.kkr.com&amp;index=1&amp;md5=dffc7955f5937e64d46ab75a736d913e" shape="rect">www.kkr.com</a>. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.globalatlantic.com&amp;esheet=54566825&amp;newsitemid=20260707491568&amp;lan=en-US&amp;anchor=www.globalatlantic.com&amp;index=2&amp;md5=4846ef5e5420663c5a5b9ff345218f36" shape="rect">www.globalatlantic.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About Allyntra</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Allyntra is a leading engineered solutions partner to the medical technology industry, specializing in the design, development, and manufacture of highly engineered components and assemblies for advanced surgical applications. We collaborate with the world’s leading medtech innovators to accelerate the development and commercialization of next-generation technologies, including robotic-assisted surgery, minimally invasive surgery, and advanced surgical systems.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260707491568r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260707491568/en/" rel="nofollow">https://www.businesswire.com/news/home/20260707491568/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">KKR
<br xmlns="http://www.w3.org/1999/xhtml"></br></b>Media
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:media@kkr.com" shape="rect">media@kkr.com 
</a><br xmlns="http://www.w3.org/1999/xhtml"></br>
<br xmlns="http://www.w3.org/1999/xhtml"></br><b xmlns="http://www.w3.org/1999/xhtml">Allyntra
<br xmlns="http://www.w3.org/1999/xhtml"></br></b>Media
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:media@allyntra.com" shape="rect">media@allyntra.com</a>

</p>

KKR unveiled Allyntra, a new precision-engineered solutions platform anchored by Precipart, with capital to pursue bolt-on acquisitions and growth. Robbie Atkinson will lead as CEO and Brian Highley as Chairman, with Oliver Laubscher joining the board as Precipart transitions. The move broadens KKR's healthcare technology footprint and could lift value over the coming years through expanded capabilities and customer deployments.

KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News